Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Share-based Compensation (2016 - 2025)

Nutex Health's Share-based Compensation history spans 10 years, with the latest figure at -$2.6 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 117.71% year-over-year to -$2.6 million; the TTM value through Dec 2025 reached $117.0 million, up 601.42%, while the annual FY2025 figure was $117.0 million, 604.82% up from the prior year.
  • Share-based Compensation for Q4 2025 was -$2.6 million at Nutex Health, down from $4.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $78.7 million in Q2 2025 and bottomed at -$3.9 million in Q2 2021.
  • The 5-year median for Share-based Compensation is $637188.0 (2023), against an average of $8.2 million.
  • The largest annual shift saw Share-based Compensation crashed 371.71% in 2021 before it surged 129193.44% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $4.0 million in 2021, then crashed by 98.65% to $54166.0 in 2022, then soared by 1076.36% to $637188.0 in 2023, then surged by 2203.94% to $14.7 million in 2024, then plummeted by 117.71% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Share-based Compensation are -$2.6 million (Q4 2025), $4.8 million (Q3 2025), and $78.7 million (Q2 2025).